Population-based Incidence of Myopericarditis After COVID-19 Vaccination in Danish Adolescents

Pediatr Infect Dis J. 2022 Jan 1;41(1):e25-e28. doi: 10.1097/INF.0000000000003389.

Abstract

In this prospective nationwide multicenter study from Denmark, myopericarditis after Pfizer-BioNTech mRNA COVID-19 vaccination was identified in 13 males and 2 females between May 15 and September 15, 2021, among 133,477 vaccinated males and 127,857 vaccinated females 12-17 years of age, equaling 97 males and 16 females per million. In conclusion, the incidence of myopericarditis after COVID-19 vaccination among males appears higher than reports from the United States.

Publication types

  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • BNT162 Vaccine / adverse effects*
  • Child
  • Denmark / epidemiology
  • Female
  • Humans
  • Incidence
  • Male
  • Myocarditis / chemically induced*
  • Myocarditis / epidemiology*
  • Pericarditis / chemically induced*
  • Pericarditis / epidemiology*
  • Prospective Studies

Substances

  • BNT162 Vaccine